1.Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
Young Eun AHN ; Sang Jun SUH ; Hyung Joon YIM ; Yeon Seok SEO ; Eileen L. YOON ; Tae Hyung KIM ; Young Sun LEE ; Sun Young YIM ; Hae Rim KIM ; Seong Hee KANG ; Young Kul JUNG ; Ji Hoon KIM ; Jong Eun YEON ; Soon Ho UM ; Kwan Soo BYUN
Gut and Liver 2021;15(2):284-294
Background/Aims:
Sorafenib is the first approved systemic treatment for advanced hepatocellular carcinoma (HCC). However, its clinical utility is limited, especially in Asian countries. Several reports have suggested the survival benefits of hepatic arterial infusion chemotherapy (HAIC) for advanced HCC with main portal vein tumor thrombosis (PVTT). This study aimed to compare the efficacy of sorafenib-based therapy with that of HAIC-based therapy for advanced HCC with main PVTT.
Methods:
Advanced HCC patients with main PVTT treated with sorafenib or HAIC between 2008 and 2016 at Korea University Medical Center were included. We evaluated overall survival (OS), time-to-progression (TTP), and the disease control rate (DCR).
Results:
Seventy-three patients were treated with sorafenib (n=35) or HAIC (n=38). Baseline characteristics were not significantly different between groups, except the presence of solid organ metastasis (46% vs 5.3%, p<0.001). The median OS time was not significantly different between the groups (6.4 months vs 10.0 months, p=0.139). TTP was longer in the HAIC group than in the sorafenib group (2.1 months vs 6.2 months, p=0.006). The DCR was also better in the HAIC group than in the sorafenib group (37% vs 76%, p=0.001). Subgroup analysis, which excluded patients with extrahepatic solid organ metastasis, showed the same trends for the median OS time (8.8 months vs 11.1 months, p=0.097), TTP (1.9 months vs 6.0 months, p<0.001), and DCR (53% vs 81%, p=0.030).
Conclusions
HAIC-based therapy may be an alternative to sorafenib for advanced HCC with main PVTT by providing longer TTP and a better DCR.
2.Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms
Young Sun LEE ; Yeon Seok SEO ; Ji Hoon KIM ; Juneyoung LEE ; Hae Rim KIM ; Yang Jae YOO ; Tae Suk KIM ; Seong Hee KANG ; Sang Jun SUH ; Moon Kyung JOO ; Young Kul JUNG ; Beom Jae LEE ; Hyung Joon YIM ; Jong Eun YEON ; Jae Seon KIM ; Jong Jae PARK ; Soon Ho UM ; Young Tae BAK ; Kwan Soo BYUN
Gut and Liver 2018;12(1):94-101
BACKGROUND/AIMS: In addition to the globally endorsed Barcelona Clinic Liver Cancer (BCLC) staging system, other algorithms or staging systems have been developed, including the Hong Kong Liver Cancer (HKLC) staging system. This study aimed to validate the HKLC staging system relative to the BCLC staging system for predicting survival for hepatocellular carcinoma (HCC) patients in Korea. METHODS: From 2004 to 2013, 2,571 patients newly diagnosed with HCC were consecutively enrolled at three Korea University medical centers. RESULTS: Both staging systems differentiated survival well (p < 0.001). However, 1-year and 3-year survival were predicted better using the HKLC system than the BCLC system (area under the receiver operating characteristic curve: 0.869 vs 0.856 for 1 year, p=0.002; 0.841 vs 0.827 for 3 years, p=0.010). In hypothetical survival curves, the HKLC system exhibited better median overall survival than the BCLC system (33.1 months vs 19.2 months). In evaluations of prognosis according to either BCLC or HKLC treatment guidelines, risk of death was reduced in the group following only HKLC guidelines compared with the group following only BCLC guidelines (hazard ratio, 0.601; 95% confidence interval, 0.443 to 0.816; p=0.001). CONCLUSIONS: Although both staging systems predicted and discriminated HCC prognoses well, the HKLC system showed more encouraging survival benefits than the BCLC system.
Academic Medical Centers
;
Carcinoma, Hepatocellular
;
Hong Kong
;
Humans
;
Korea
;
Liver Neoplasms
;
Liver
;
Neoplasm Staging
;
Prognosis
;
ROC Curve
3.Clinical Characteristics of Febrile UTI First Developed Over 5 Years of Age.
Da Eun ROH ; Hyo Rim SUH ; So Yoon MIN ; Tae Kyoung JO ; Hee Sun BAEK ; Min Hyun CHO
Childhood Kidney Diseases 2017;21(1):15-20
PURPOSE: Febrile urinary tract infection (UTI) is one of the commonest bacterial infections in children. The purpose of this study is to investigate the clinical characteristics of the first episode of febrile UTI occurring in children over 5 years compared to those in infants younger than a year. METHODS: We retrospectively reviewed the medical records of 10 patients over 5 years, having febrile UTI, and 25 controls under 1 year. Clinical characteristics including symptoms at admission, the time interval between symptom onset and hospital visit and/or diagnosis, duration of fever, urinalysis, and other laboratory and imaging test results were compared between the two groups. RESULTS: Most patients in the control group showed only high fever at the time of presentation to the hospital. However, 60% of the case group had fever along with gastrointestinal (GI) symptoms such as abdominal and flank pain, vomiting, as well as relatively mild pyuria. The case group showed a longer duration between symptom onset and hospital visit and/or diagnosis. CONCLUSIONS: Delay in diagnosis and initiation of treatment of UTI increases the risk of permanent renal scarring and associated complications. Therefore, early diagnosis and treatment of febrile UTI is vital for very young infants, as well as children considering that febrile UTI could be an important cause of febrile illness in children over 5 years.
Bacterial Infections
;
Child
;
Cicatrix
;
Diagnosis
;
Early Diagnosis
;
Fever
;
Flank Pain
;
Humans
;
Infant
;
Medical Records
;
Pyuria
;
Retrospective Studies
;
Urinalysis
;
Urinary Tract Infections
;
Vomiting
4.Sleep Problems and Daytime Sleepiness in Children with Nocturnal Enuresis.
Yun Mo GU ; Jung Eun KWON ; Gimin LEE ; Su Jeong LEE ; Hyo Rim SUH ; Soyoon MIN ; Da Eun ROH ; Tae Kyoung JO ; Hee Sun BAEK ; Suk Jin HONG ; Hyeeun SEO ; Min Hyun CHO
Childhood Kidney Diseases 2016;20(2):50-56
PURPOSE: Nocturnal enuresis (NE) is one of the most common problems in childhood. NE has a multifactorial etiology and is influenced by sleep and arousal mechanisms. The aim of the present study was to prospectively evaluate sleep problems and patterns in children with NE compared with normal healthy controls. METHODS: Twenty-eight children with NE and 16 healthy controls were included in the study. To evaluate sleep habits and disturbances, parents and children filled out a questionnaire that included items about sleep patterns and sleep-related behaviors prior to treatment for NE. Demographic factors and other data were compared for the two groups based on the responses to the sleep questionnaire. RESULTS: Night awakening, sleepwalking, and periodic limb movements were more prevalent in children with NE, but symptoms of sleep-disordered breathing were not increased in this group. There were statistically significant differences in periodic limb movements and daytime sleepiness between the two groups. CONCLUSION: Children with NE seemed to have more sleep problems such as night awakening, sleepwalking, and periodic limb movements. In addition, a higher level of daytime sleepiness and hyperactivity in patients with NE suggested a relationship between NE and sleep disorders.
Arousal
;
Child*
;
Demography
;
Extremities
;
Humans
;
Nocturnal Enuresis*
;
Parents
;
Prospective Studies
;
Sleep Apnea Syndromes
;
Sleep Wake Disorders
;
Somnambulism
5.Opioid sparing effect of low dose ketamine in patients with intravenous patient-controlled analgesia using fentanyl after lumbar spinal fusion surgery.
Sang Ho KIM ; Soon Im KIM ; Si Young OK ; Sun Young PARK ; Mun Gyu KIM ; Se Jin LEE ; Jung Il NOH ; Hea Rim CHUN ; Haejin SUH
Korean Journal of Anesthesiology 2013;64(6):524-528
BACKGROUND: The opioid sparing effect of low dose ketamine is influenced by bolus dose, infusion rate, duration of infusion, and differences in the intensity of postoperative pain. In this study, we investigated the opioid sparing effect of low dose ketamine in patients with intravenous patient-controlled analgesia (PCA) using fentanyl after lumbar spinal fusion surgery, which can cause severe postoperative pain. METHODS: Sixty patients scheduled for elective lumbar spinal fusion surgery were randomly assigned to receive one of three study medications (K1 group: ketamine infusion of 1 microg/kg/min following bolus 0.5 mg/kg, K2 group: ketamine infusion of 2 microg/kg/min following bolus 0.5 mg/kg, Control group: saline infusion following bolus of saline). Continuous infusion of ketamine began before skin incision intraoperatively, and continued until 48 h postoperatively. For postoperative pain control, patients were administered fentanyl using IV-PCA (bolus dose 15 microg of fentanyl, lockout interval of 5 min, no basal infusion). For 48 h postoperatively, the total amount of fentanyl consumption, postoperative pain score, adverse effects and patients' satisfaction were evaluated. RESULTS: The total amount of fentanyl consumption was significantly lower in the K2 group (474 microg) compared to the control group (826 microg) and the K1 group (756 microg) during the 48 h after surgery. Pain scores at rest or with movement, the incidence of adverse events and patient satisfaction were not significantly different among the groups. CONCLUSIONS: Low-dose ketamine at 2 microg/kg/min following bolus 0.5 mg/kg significantly reduced the total amount of fentanyl consumption during the 48 h after lumbar spinal fusion surgery without increasing adverse effects.
Analgesia, Patient-Controlled
;
Fentanyl
;
Humans
;
Incidence
;
Ketamine
;
Pain, Postoperative
;
Patient Satisfaction
;
Skin
;
Spinal Fusion
6.Clostridium difficile-associated diarrhea in dialysis patients.
Sook Eui OH ; Seung Min LEE ; Young Ki LEE ; Sun Ryoung CHOI ; Myung Jin CHOI ; Jwa Kyung KIM ; Young Rim SONG ; Soo Jin KIM ; Tae Jin PARK ; Sung Gyun KIM ; Jieun OH ; Jang Won SUH ; Jong Woo YOON ; Ja Ryong KOO ; Hyung Jik KIM ; Jung Woo NOH
Kidney Research and Clinical Practice 2013;32(1):27-31
BACKGROUND: Dialysis patients have impaired host defense mechanisms and frequently require antibiotics for various infective complications. In this study, we investigated whether dialysis patients have greater risk for Clostridium difficile-associated diarrhea (CDAD). METHODS: During the 4-year study period (2004-2008), 85 patients with CDAD were identified based on a retrospective review of C difficile toxin assay or histology records. Nosocomial diarrheal patients without CDAD were considered as controls (n=403). We assessed the association between renal function and the prevalence and clinical outcomes of CDAD. RESULTS: There was a significant difference in the prevalence rate of chronic kidney disease (CKD) between CDAD and non-CDAD patients (P<0.001). Sixteen patients (18.8%) of the CDAD group were treated with dialysis, whereas 21 patients (5.2%) of the non-CDAD group were treated with dialysis. There was a significant association between renal function and CDAD in patients on dialysis [odds ratio (OR)=4.44, 95% confidence interval (CI) 2.19-8.99, P<0.001], but not in patients with CKD stage 3-5 (OR=1.10, 95% CI 0.63-1.92, P=0.73). In multivariate analysis, CKD stage 5D was an independent risk factor for the development of CDAD (OR=13.36, 95% CI 2.94-60.67, P=0.001). CONCLUSION: Our data indicate that dialysis patients might be at a greater risk of developing CDAD, which suggests that particular attention should be provided to CDAD when antibiotic treatment is administered to dialysis patients.
Anti-Bacterial Agents
;
Clostridium
;
Clostridium difficile
;
Defense Mechanisms
;
Dialysis
;
Diarrhea
;
Humans
;
Multivariate Analysis
;
Prevalence
;
Renal Insufficiency, Chronic
;
Retrospective Studies
;
Risk Factors
7.Clostridium difficile-associated diarrhea in dialysis patients.
Sook Eui OH ; Seung Min LEE ; Young Ki LEE ; Sun Ryoung CHOI ; Myung Jin CHOI ; Jwa Kyung KIM ; Young Rim SONG ; Soo Jin KIM ; Tae Jin PARK ; Sung Gyun KIM ; Jieun OH ; Jang Won SUH ; Jong Woo YOON ; Ja Ryong KOO ; Hyung Jik KIM ; Jung Woo NOH
Kidney Research and Clinical Practice 2013;32(1):27-31
BACKGROUND: Dialysis patients have impaired host defense mechanisms and frequently require antibiotics for various infective complications. In this study, we investigated whether dialysis patients have greater risk for Clostridium difficile-associated diarrhea (CDAD). METHODS: During the 4-year study period (2004-2008), 85 patients with CDAD were identified based on a retrospective review of C difficile toxin assay or histology records. Nosocomial diarrheal patients without CDAD were considered as controls (n=403). We assessed the association between renal function and the prevalence and clinical outcomes of CDAD. RESULTS: There was a significant difference in the prevalence rate of chronic kidney disease (CKD) between CDAD and non-CDAD patients (P<0.001). Sixteen patients (18.8%) of the CDAD group were treated with dialysis, whereas 21 patients (5.2%) of the non-CDAD group were treated with dialysis. There was a significant association between renal function and CDAD in patients on dialysis [odds ratio (OR)=4.44, 95% confidence interval (CI) 2.19-8.99, P<0.001], but not in patients with CKD stage 3-5 (OR=1.10, 95% CI 0.63-1.92, P=0.73). In multivariate analysis, CKD stage 5D was an independent risk factor for the development of CDAD (OR=13.36, 95% CI 2.94-60.67, P=0.001). CONCLUSION: Our data indicate that dialysis patients might be at a greater risk of developing CDAD, which suggests that particular attention should be provided to CDAD when antibiotic treatment is administered to dialysis patients.
Anti-Bacterial Agents
;
Clostridium
;
Clostridium difficile
;
Defense Mechanisms
;
Dialysis
;
Diarrhea
;
Humans
;
Multivariate Analysis
;
Prevalence
;
Renal Insufficiency, Chronic
;
Retrospective Studies
;
Risk Factors
8.Awake during General Anesthesia with BispectralIndex Value of 35.
Sejin LEE ; Soon Im KIM ; Si Young OK ; Sang Ho KIM ; Sun Young PARK ; Mun Gyu KIM ; Hye Rim JEON ; Hae Jin SUH ; A Na CHO ; Sekwang PARK
Soonchunhyang Medical Science 2013;19(1):29-30
Awareness of intraoperative events in patients under general anesthesia is rare, but awareness during anesthesia is a serious complication that leads to anxiety and post-traumatic stress disorder. The Bispectral Index (BIS) has generally been accepted as a measurement of hypnosis under anesthesia. It is derived from a processed electroencephalogram and computer algorithm that assigns a numerical value based on the probability of consciousness. A 46-year-old, 65-kg male without underlying disease underwent elective surgery for ventral hernia. The patient in this case was administered an anesthetic that we frequently use and then average BIS value are 35. But he experienced awake during general anesthesia. We describe the first case of intraoperation awake under BIS 40 using desflurane.
Anesthesia
;
Anesthesia, General
;
Anxiety
;
Consciousness
;
Consciousness Monitors
;
Electroencephalography
;
Hernia, Ventral
;
Humans
;
Hypnosis
;
Intraoperative Awareness
;
Intraoperative Complications
;
Isoflurane
;
Male
;
Mental Recall
;
Stress Disorders, Post-Traumatic
9.A case of necrotizing pancreatitis subsequent to transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma.
Song I BAE ; Jong Eun YEON ; Jong Mee LEE ; Ji Hoon KIM ; Hyun Jung LEE ; Sun Jae LEE ; Sang Jun SUH ; Eileen L YOON ; Hae Rim KIM ; Kwan Soo BYUN ; Tae Seok SEO
Clinical and Molecular Hepatology 2012;18(3):321-325
Necrotizing pancreatitis is one of the rare complications of transcatheter arterial chemoembolization (TACE). Necrotizing pancreatitis after TACE may result from the development of ischemia caused by regurgitation of embolic materials into the vessels supplying the pancreas. We report a case of post-TACE necrotizing pancreatitis with abscess formation in a patient with hepatocellular carcinoma. The patient had suffered hepatic artery injury due to repetitive TACE; during his 25th TACE procedure he had submitted to selective catheterization of the feeding vessel from the dorsal pancreatic artery with a cytotoxic agent and Gelfoam particles. The patient complained of abdominal pain after the TACE procedure, and a CT scan led to a diagnosis of necrotizing pancreatitis with abscess formation. The pancreatic abscess progressed despite general management of the pancreatitis, including antibiotics. Percutaneous catheter drainage was performed, and the symptoms of the patient improved.
Abscess/microbiology
;
Aged
;
Anti-Bacterial Agents/therapeutic use
;
Carcinoma, Hepatocellular/*complications/*therapy
;
Chemoembolization, Therapeutic/*adverse effects
;
Cholangiopancreatography, Endoscopic Retrograde
;
Citrobacter freundii/isolation & purification
;
Drainage
;
Drug Resistance, Multiple, Bacterial
;
Enterobacteriaceae Infections/drug therapy
;
Hepatitis B/complications
;
Humans
;
Klebsiella/isolation & purification
;
Klebsiella Infections/drug therapy
;
Liver Cirrhosis/etiology
;
Liver Neoplasms/*complications/*therapy
;
Male
;
Necrosis/*diagnosis/etiology
;
Pancreatitis/*diagnosis/etiology
;
Tomography, X-Ray Computed
10.Uncertainty and Nursing Need According to Illness Phases in Cancer Patients.
Mi Sun LEE ; Hee Ju KIM ; Soon Rim SUH
Journal of Korean Academy of Adult Nursing 2008;20(1):1-9
PURPOSES: This study examined uncertainty and nursing need according to illness phases(phase I, II, III) in cancer patients, and investigated relationships between uncertainty and nursing need. METHODS: A cross-sectional descriptive study was conducted with a sample of 121 adult cancer patients treated in two hospitals. RESULTS: As for the total score, the uncertainty was not significantly different across the subgroups by illness phase. As for the subscale score, however, two sub-scales of the uncertainty were different across the subgroups. 'The unpredictability' was highest in illness phase I and II groups, while 'the lack of information' was highest in the illness phase III group. Nursing need as the total score was not significantly different across the subgroups by illness phase. However, all subscale scores of the nursing need were significantly different across the subgroups. Educational need was highest in the illness phase I group; physical and emotional needs were highest in the illness phase III group. Uncertainty and nursing need were not related to each other at any illness phase. CONCLUSION: The results suggest that nursing need and uncertainty may change across illness phases. Clinicians need to consider this pattern in caring for cancer patients.
Adult
;
Humans
;
Uncertainty

Result Analysis
Print
Save
E-mail